ALOFT-IPF
Who is this for?
Those with idiopathic pulmonary fibrosis (IPF)
Study:
This study looks at the drug BMS-986278. It aims to evaluate the efficacy of two different doses of the investigational drug, as well as its safety and tolerability.
Those with idiopathic pulmonary fibrosis (IPF)
This study looks at the drug BMS-986278. It aims to evaluate the efficacy of two different doses of the investigational drug, as well as its safety and tolerability.